The University of Glasgow has launched the next wave of deep tech ventures into accelerated growth, following with the Infinity G cohort.
Fourteen startups, spanning wearable brain diagnostics, medtech implants, quantum computing electronics, AI-driven pathology and immersive technologies, are now moving forward with sharpened commercial strategies, stronger brands and direct access to investors and industry partners.
Infinity G, Scotland’s first deep tech accelerator, is designed not as an endpoint but as a launch platform , equipping founders with the confidence, networks, and tools to take breakthrough research into global markets.
Delivered over 13 weeks at thebeyond workspace in Finnieston, and in collaboration with STAC at Skypark and the Glasgow Riverside Innovation District, the programme blends expert mentorship, brand-building, funding insight, and intensive pitch development to prepare ventures for scale.
From research to market readiness
The cohort reflects the breadth of entrepreneurial ambition emerging from across the University -including three student-led ventures and spin-outs rooted in world-leading research in medical technology, quantum engineering, AI, and virtual reality.
Among them is Kelvin Quantum, a University of Glasgow spin-out developing specialised high-performance electronics designed to operate at cryogenic temperatures in quantum computing systems.
As well as health tech startup TileBio, rooted in research from the University of Glasgow and Cancer Research UK, is building an “AI-learned visual language of tissue” to revolutionise cancer diagnostics and digital pathology.

Building ambitious, investment-ready ventures
Ventures were selected for the strength of their propositions, the drive of their founders, and the potential impact of their technologies across sectors.
Throughout the programme, founders will participate in workshops & events covering brand strategy, IP creation, strategic hiring, and investment readiness. External speakers will insights into venture capital decision-making, while regular pitching sessions will help refine narratives and accelerate the journey from research to revenue.
The cohort includes: Brain Dynamics; FlashSens; HELM; TileBio; Museums in the Metaverse; Kelvin Quantum; Bina Networks; AI Stat; Authrive; Lotus DX; Quantatrac; Radana; Theo Health; and VascuX.
Strategy
The creation of spin-out companies is at the heart of the University’s Innovation Strategy (2022-25). In 2024, the University’s top six spin-outs raised investment of more than £60 million, creating 250 jobs across a range of commercial and spin-out activity, and awarded more than £600,000 to 23 projects with commercial or spin-out potential as part of major funding drives in Medtech and the Arts and Humanities.
The University is also working with its partners Scottish Enterprise and Glasgow City Council to deliver jobs, training opportunities and economic growth through Glasgow Riverside Innovation District.




